title: Redefining clinical trials: the age of personalized medicine.
abstract: The triumph of personalized cancer therapeutics in recent years is prompting some oncologists to rethink clinical trial design; other researchers have different priorities for trial reform.
authors.forename: Gayathri
authors.initials: G
authors.lastname: Vaidyanathan
mesh_terms: D002986:Clinical Trials as Topic; D000077547:Crizotinib; D055106:Genome-Wide Association Study; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D057285:Precision Medicine; D011720:Pyrazoles / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic
chemical_list: D011720:Pyrazoles; D011725:Pyridines; D000077547:Crizotinib